INTANGIBLE ASSETS AND INTERNAL-USE SOFTWARE, NET - Narrative (Details) - USD ($) |
1 Months Ended | 3 Months Ended | 9 Months Ended | |||
---|---|---|---|---|---|---|
Nov. 03, 2023 |
Sep. 30, 2023 |
Sep. 30, 2022 |
Mar. 31, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
|
Finite-Lived Intangible Assets [Line Items] | ||||||
Capitalized internal-use software development costs | $ 5,500,000 | $ 5,600,000 | $ 17,900,000 | $ 17,600,000 | ||
Amortization | 10,300,000 | $ 7,400,000 | 29,500,000 | 22,200,000 | ||
Impairment charges for internal-use software | $ 1,100,000 | $ 0 | $ 1,100,000 | $ 8,400,000 | ||
Subsequent Event | Licenses | ||||||
Finite-Lived Intangible Assets [Line Items] | ||||||
Increase in intangible assets and internal-use software, net | $ 32,000,000 | |||||
Minimum guarantee liabilities | $ 32,000,000 |
X | ||||||||||
- Definition Licensing Guarantee Liability No definition available.
|
X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Additions made to capitalized computer software costs during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of impairment loss from capitalized computer software costs. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|